| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100502911C An anti-rheumatism medicament and preparation method thereof |
| 06/24/2009 | CN100502906C External-applied ointment of skin tinea and preparation thereof |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502873C Formulations containing cephalosporin |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/23/2009 | US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550440 aqueous emulsion for the treatment of rosacea skin disorders, acne, dermatitis; Glycerol, Isopropyl palmitate, Cetyl alcohol, Stearyl monostearate, Oleyl alcohol, Ceteareth-20; good cosmetic properties and long shelf-life with minimum of 2 years |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2320628C Chelated 8-hydroxyquinoline for the treatment of epithelial lesions |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/21/2009 | CA2646775A1 Cosmetic and pharmaceutical compositions |
| 06/18/2009 | WO2009076602A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076512A1 Carboxamidξ compounds and their use as chemokine receptor agonists |
| 06/18/2009 | WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075142A1 Bactericidal cleanser composition |
| 06/18/2009 | WO2009074797A1 Methods for inhibiting scarring |
| 06/18/2009 | WO2009074339A1 Remedies for pemphigus containing anti fas ligand antobodies |
| 06/18/2009 | WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 06/18/2009 | WO2008148966A3 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof |
| 06/18/2009 | WO2008145849A3 Pharmaceutical and/or cosmetic composition containing aconitase-activating active ingredients |
| 06/18/2009 | WO2008145848A3 Pharmaceutical and/or cosmetic composition containing peptides |
| 06/18/2009 | WO2008034535A8 Method for treating skin by administering an agent that decreases gmcsf release from keratinocytes |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090156680 Deodorants Containing Aminoacid Derivatives |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156628 Aminothiazoles and their Uses |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156563 Glucan Compositions |
| 06/18/2009 | US20090156482 External preparation, method of producing the same and usage for the same |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155395 SF303T, Anti-Inflammatory and Anti-Acne Agent |
| 06/18/2009 | US20090155383 Personal Care Compositions Comprising Undecyl Sulfates |
| 06/18/2009 | US20090155366 Osteoinductive materials |
| 06/18/2009 | US20090155325 Formulation and products for promoting skin cleanliness and health |
| 06/18/2009 | US20090155324 Skin Treatment System |
| 06/18/2009 | US20090155323 Skin cosmetic composition |
| 06/18/2009 | US20090155319 Method for producing cosmetic and/or dermatological powder |
| 06/18/2009 | US20090155314 Dermal filler |
| 06/18/2009 | US20090155286 Type I interferon blocking agents for prevention and treatment of psoriasis |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155264 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155225 Uses and isolation of very small of embryonic-like (vsel) stem cells |
| 06/18/2009 | US20090155211 Methods and Compositions for the Treatment of Autoimmune Disorders Using Clofarabine |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | DE102005023666B4 Verwendung von Murmeltieröl zur Behandlung von Akne vulgaris, Akne rosacea, Venenentzündungen, Herpes oder äußerlichen Hämorrhoiden Use of marmot oil for the treatment of acne vulgaris, acne rosacea, phlebitis, herpes or external hemorrhoids |
| 06/18/2009 | CA2733794A1 Methods for the inhibition of scarring |
| 06/18/2009 | CA2709314A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709007A1 Methods for inhibiting scarring |
| 06/18/2009 | CA2708790A1 Remedies for pemphigus containing anti fas ligand antibodies |
| 06/18/2009 | CA2706811A1 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2070927A1 Fused heterocyclic derivative |
| 06/17/2009 | EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070533A1 Use of a compound derived from P-hydroxyphenyl propionic acid for the treatment of psoriasis |
| 06/17/2009 | EP2070531A1 Pharmaceutical preparation containing histamine H2-receptor antagonists having wound healing activity at low doses |
| 06/17/2009 | EP2070513A1 Antioxidant combinations with 6,7 disubstituted 2.2-dialkylchromanes or chromenes |
| 06/17/2009 | EP2069377A2 Methods and compositions for the treatment of skin diseases and disorders |
| 06/17/2009 | EP2069322A2 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 06/17/2009 | EP2069297A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 06/17/2009 | EP2069296A2 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 06/17/2009 | EP2068931A1 Treatment of fibrosis |
| 06/17/2009 | EP2068920A2 Ccr2 antagonists for treatment of fibrosis |
| 06/17/2009 | EP2068892A1 Wound healing compositions |
| 06/17/2009 | EP2068873A2 Isoniazid mediated healing of wounds and ulcers |
| 06/17/2009 | EP1740591B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 06/17/2009 | EP1602669B1 Antibody against a tumor-specific antigen as target |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | CN100500663C N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 06/17/2009 | CN100500140C Dermal compositions containing coenzyme Q as active ingredient |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |